Disclosed herein is a pharmaceutical composition for preventing, alleviating or treating neurodegenerative diseases. The pharmaceutical composition contains, as active ingredients, Curcumae longae rhizome, Gastrodiae rhizoma, Polygalae radix, Salviae radix, Chaenomeles fructus, Paeoniae radix, Glycyrrhizae radix, Atractylodis rhizome, and Pulvis aconiti tuberis purificatum. The pharmaceutical composition is prepared by a method including the steps of: mixing Curcumae longae rhizome, Gastrodiae rhizoma, Polygalae radix, Salviae radix, Chaenomeles fructus, Paeoniae radix, Glycyrrhizae radix, Atractylodis rhizome, and Pulvis aconiti tuberis purificatum to obtain a mixture, and extracting the mixture to obtain a mixture extract; filtering the mixture extract; concentrating the mixture extract; and drying the mixture extract.

An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, ligusticum wallichii, barbat skullcap, honeysuckle flower, oldenlandia diffusa, radix trichosanthis, rhizoma anemarrhenae scutellaria baicalensis, angelica sinensis psoralea corylifolia, lucid ganoderma, and coix seed.

An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, ligusticum wallichii, barbat skullcap, honeysuckle flower, oldenlandia diffusa, radix trichosanthis, rhizoma anemarrhenae scutellaria baicalensis, angelica sinensis psoralea corylifolia, lucid ganoderma, and coix seed.

An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, ligusticum wallichii, barbat skullcap, honeysuckle flower, oldenlandia diffusa, radix trichosanthis, rhizoma anemarrhenae scutellaria baicalensis, angelica sinensis psoralea corylifolia, lucid ganoderma, and coix seed.

A beverage or food additive for improving an individual's mental and physiological performance, the dietary composition comprising medium chain triglycerides oil, Ginko Biloba, Panax Ginseng, phosphatidylserine, Bacopa Monnieri, and Polygala Tenuifolia. In addition, the dietary composition may optionally contain docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and/or epigallocatechin gallate (EGCG).

A beverage or food additive for improving an individual's mental and physiological performance, the dietary composition comprising medium chain triglycerides oil, Ginko Biloba, Panax Ginseng, phosphatidylserine, Bacopa Monnieri, and Polygala Tenuifolia. In addition, the dietary composition may optionally contain docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and/or epigallocatechin gallate (EGCG).

A beverage or food additive for improving an individual's mental and physiological performance, the dietary composition comprising medium chain triglycerides oil, Ginko Biloba, Panax Ginseng, phosphatidylserine, Bacopa Monnieri, and Polygala Tenuifolia. In addition, the dietary composition may optionally contain docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and/or epigallocatechin gallate (EGCG).

Provided are an HDC activation inhibitor and an antipruritic agent which are effective in animals against the itch caused by a itch generation mechanism different from the well-known one.

An HDC activation inhibitor or antipruritic agent which is at least one member selected from (1) a particular flavonoid, (2) a tannin, (3) chlorogenic acid, (4) a particular stilbenoid, or a glucoside or pharmaceutically acceptable derivative of any of (1) to (4) given above, or (5) a particular crude drug extract, (6) walnut polyphenol.

Provided are an HDC activation inhibitor and an antipruritic agent which are effective in animals against the itch caused by a itch generation mechanism different from the well-known one.

An HDC activation inhibitor or antipruritic agent which is at least one member selected from (1) a particular flavonoid, (2) a tannin, (3) chlorogenic acid, (4) a particular stilbenoid, or a glucoside or pharmaceutically acceptable derivative of any of (1) to (4) given above, or (5) a particular crude drug extract, (6) walnut polyphenol.

Provided are an HDC activation inhibitor and an antipruritic agent which are effective in animals against the itch caused by a itch generation mechanism different from the well-known one.

An HDC activation inhibitor or antipruritic agent which is at least one member selected from (1) a particular flavonoid, (2) a tannin, (3) chlorogenic acid, (4) a particular stilbenoid, or a glucoside or pharmaceutically acceptable derivative of any of (1) to (4) given above, or (5) a particular crude drug extract, (6) walnut polyphenol.